Author: Mucha, Artur; Drag, Marcin; Dalton, John P.; Kafarski, Paweł
Title: Metallo-aminopeptidase inhibitors Cord-id: do0px1gq Document date: 2010_5_10
ID: do0px1gq
Snippet: Aminopeptidases are enzymes that selectively hydrolyze an amino acid residue from the N-terminus of proteins and peptides. They are important for the proper functioning of prokaryotic and eukaryotic cells, but very often are central players in the devastating human diseases like cancer, malaria and diabetes. The largest aminopeptidase group include enzymes containing metal ion(s) in their active centers, which often determines the type of inhibitors that are the most suitable for them. Effective
Document: Aminopeptidases are enzymes that selectively hydrolyze an amino acid residue from the N-terminus of proteins and peptides. They are important for the proper functioning of prokaryotic and eukaryotic cells, but very often are central players in the devastating human diseases like cancer, malaria and diabetes. The largest aminopeptidase group include enzymes containing metal ion(s) in their active centers, which often determines the type of inhibitors that are the most suitable for them. Effective ligands mostly bind in a non-covalent mode by forming complexes with the metal ion(s). Here, we present several approaches for the design of inhibitors for metallo-aminopeptidases. The optimized structures should be considered as potential leads in the drug discovery process against endogenous and infectious diseases.
Search related documents:
Co phrase search for related documents- action mechanism and liver infection: 1, 2
- action mechanism and low activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- action mechanism and low micromolar: 1, 2, 3, 4, 5, 6, 7, 8
- action mechanism and low micromolar range: 1, 2, 3, 4, 5
- action mechanism and low molecular weight: 1, 2
- action mechanism and low nanomolar range: 1, 2, 3, 4
- action mechanism and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- active site and additional role: 1
- active site and additional target: 1, 2, 3, 4
- active site and liver infection: 1
- active site and low activity: 1, 2, 3, 4, 5
- active site and low micromolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- active site and low micromolar range: 1, 2, 3, 4, 5, 6
- active site and low molecular weight: 1, 2, 3, 4
- active site and low nanomolar potency: 1
- active site and low nanomolar range: 1, 2
- active site and lung disease: 1
- active site enzyme and additional target: 1
- active site enzyme and low micromolar: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date